| Financial Year |
March 31 2023 |
| Monetary Funds |
2,210,678,720.66 |
| Held-for-trading Financial Assets |
25,610,670.83 |
| Notes Receivable |
-- |
| Accounts Receivable |
90,777,999.41 |
| Advances to Suppliers |
109,196,325.82 |
| Other Receivables |
513,900,078.46 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
12,985,064,301.16 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
662,793,909.74 |
| Total Current Assets |
16,599,990,493.50 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
525,701,310.80 |
| Investment Properties |
1,400,491,081.06 |
| Fixed Assetes |
256,610,507.59 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
9,977,101.34 |
| R&D expenses |
-- |
| Goodwill |
1,396,607.14 |
| Long-Term Deferred and Prepaid Expenses |
2,065,421.66 |
| Deferred Income Tax Assets |
228,970,653.32 |
| Other Non-Current Assets |
131,248,604.81 |
| Sub-Total of Non-Current Assets |
2,798,254,471.24 |
| Total Assets |
19,398,244,964.74 |
| Short-Term Loans |
159,614,911.17 |
| Trading Financial liabilities |
283,570.00 |
| Notes Payable |
1,019,283,445.00 |
| Accounts Payable |
892,328,253.04 |
| Accounts Received In Advance |
2,718,396.70 |
| Employee Compensation Payable |
5,907,326.27 |
| Taxes Payable |
306,617,236.71 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,078,899,279.13 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
449,878,976.83 |
| Other Current Liabilities |
381,327,583.98 |
| Sub-Total of Current Liabilities |
11,424,429,562.83 |
| Long-term Loans |
3,070,265,851.89 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
3,297,801.00 |
| Deferred Income Tax Liabilities |
19,233,172.81 |
| Other Non-Current Liabilities |
168,916,359.15 |
| Sub-Total of Non-Current Liabilities |
3,261,741,184.85 |
| Total Liabilities |
14,686,170,747.68 |
| Paid-In Capital(Or Share Stock) |
774,144,175.00 |
| Capital Surplus |
847,474,480.61 |
| Surplus Reserve |
275,851,663.94 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,164,607,594.90 |
| Minority Stockholder's Interest |
649,996,302.61 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,062,077,914.45 |
| Owner's Equity（Stockholder's Equity） |
4,712,074,217.06 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
19,398,244,964.74 |
